BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

Compounds That Target EIF2AK1

Eukaryotic translation initiation factor 2-alpha kinase 1 · 14 compounds in BiohacksAI corpus

EIF2AK1 (Eukaryotic translation initiation factor 2-alpha kinase 1) is a biological target with 14 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into EIF2AK1 modulation for therapeutic and biohacking applications.

All 14 Compounds — Ranked by Evidence
1
Alvocidib
4.52
confidence
2
Foretinib
4.34
confidence
3
Bosutinib
4.08
confidence
4
Midostaurin
3.85
confidence
5
Silmitasertib
3.78
confidence
6
Abemaciclib
3.66
confidence
7
Baricitinib
3.56
confidence
8
Fedratinib
3.40
confidence
9
Dabrafenib
3.30
confidence
10
Defosbarasertib
2.89
confidence
11
Cediranib
2.83
confidence
12
Rebastinib
2.20
confidence
13
Golvatinib
2.20
confidence
14
Osi 632
1.79
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for EIF2AK1 (Eukaryotic translation initiation factor 2-alpha kinase 1). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: EIF2AK1 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.